Cited by 43Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record.

Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison

Charnaud, Ben, Griffiths, Vanessa·1998·Drug and Alcohol Dependence

Abstract

There has been a considerable increase in the number of intravenous amphetamine misusers during the last decade, and the development of effective treatment strategies for this high-risk group has become critical. The use of substitute prescribing is one option, but reservations have been expressed as to its demonstrated effectiveness in reducing injecting practice and associated risks. This study compares the effect of substitute prescribing on the injecting practices of two groups of intravenous drug misusers: 120 primary opiate misusers, prescribed oral methadone; and 60 primary amphetamine misusers, prescribed dexamphetamine elixir. The levels of intravenous drug misuse at time of discharge for the two groups was similar, with 67% of the opiate misusers and 70% of the amphetamine misusers having stopped injecting.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0376-8716(98)00052-0

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 17

  1. Connell, P.H., 1958. Amphetamine Psychosis. Maudsley Monograph No. 5. Oxford University Press, Oxford.
  2. Darke, 1994, Transitions between routes of administration of regular amphetamine users, Addiction, 89, 1077, 10.1111/j.1360-0443.1994.tb02784.x · DOI
  3. Department of Health, 1996. The Task Force to Review Services for Drugs Misusers: Report of an Independent Review of Drugs Treatment Services in England. Department of Health, London.
  4. Fleming, 1994, Is the prescription of amphetamine justified as a harm reduction measure, J. R. Soc. Health, 114, 127, 10.1177/146642409411400303 · DOI
  5. Gossop, 1995, The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users, Addiction, 90, 607, 10.1111/j.1360-0443.1995.tb02199.x · DOI
  6. Hall, 1996, Psychological morbidity and route of administration among amphetamine users in Sydney, Australia, Addiction, 91, 81, 10.1111/j.1360-0443.1996.tb03163.x · DOI
  7. Hando, 1997, Amphetamine related harms and treatment preferences of regular amphetamine users in Sydney, Australia, Drug Alcohol Depend., 46, 105, 10.1016/S0376-8716(97)00051-3 · DOI
  8. Hawkes, D., Mitcheson, M., Ogborne, A., Edwards, G., 1969. Abuse of methylamphetamine. Br. Med. J. 21 June (2), 715–721. · DOI
  9. Harris, 1993, Risk factors for HIV infection among injection drug users, J. Acquired Immune Defic. Syndr., 6, 1275
  10. Keene, 1993, Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales, Addiction, 88, 1063, 10.1111/j.1360-0443.1993.tb02125.x · DOI
  11. Klee, 1992, A new target for behavioural research—amphetamine misuse, Br. J. Addiction, 87, 439, 10.1111/j.1360-0443.1992.tb01944.x · DOI
  12. Klee, 1993, HIV risks for women drug injectors: heroin and amphetamine users compared, Addiction, 88, 1055, 10.1111/j.1360-0443.1993.tb02124.x · DOI
  13. Mattick, 1995, Drug replacement treatments: is amphetamine substitution a horse of a different colour?, Drug Alcohol Rev., 14, 389, 10.1080/09595239500185531 · DOI
  14. Pates, 1994, Speed on prescription, Druglink, May/June, 16
  15. Wallen, 1992, Possible indicators of childhood sexual abuse for individuals in substance abuse treatment, J. Child Sexual Abuse, 1, 63
  16. Weinrieb, 1993, Persistent cognitive deficits attributed to substance abuse, Neurol. Clin., 11, 663, 10.1016/S0733-8619(18)30145-2 · DOI
  17. Willoughby, S., Hager, K., Miller, J., Turner, S., 1989. Prescribing for amphetamine users in Exeter: interim report. Report of a SCODA Members Conference, 5 October 1989.

Cited by

Sorted by citations

See all 43

Metadata

Authors
Charnaud, B., & Griffiths, V.
Corresponding author
Charnaud, Ben
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
1998-09
Volume
52
Issue
1
Pages
79-84
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2059353777
Cited by
43
References
0
Citations by year
2024: 1 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 3 · 2013: 3
FWCI
2.59
Type
journal article
Language
en
Open access
closed
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
intravenous drug use, d-amphetamine, methadone, opioid misuse, opioid substitution therapy, treatment outcomes
MeSH terms
Adult, Dextroamphetamine, Dose-Response Relationship, Drug, Female, Humans, Male, Methadone, Middle Aged, Opioid-Related Disorders, Narcotics, Retrospective Studies, Severity of Illness Index, Time Factors, Substance Abuse, Intravenous, Dopamine Uptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review